Biogen, Inc. (NASDAQ/BGEN), announced today that Craig Eric Schneier, Ph.D. has been appointed Executive Vice President, Human Resources.
Dr. Schneier will oversee the company’s global human resource activities. He reports to James C. Mullen, Chairman and Chief Executive Officer. Dr. Schneier replaces Frank A. Burke, Jr., who recently retired after 16 years with Biogen.
Mr. Mullen said, “Craig Schneier has played an important role in shaping Biogen’s strategic development over the last several years and I am delighted he will be leading our human resources efforts for our 2,700 employees worldwide. His experience at Biogen and expertise in strategy execution and leadership development will be instrumental as we become a multi-product biotechnology company, and continue to experience organizational growth around the world.”
Dr. Schneier joined Biogen in 2001 as Senior Vice President, Strategic Organization Design and Effectiveness, after having served as an external consultant to the company for eight years. In this capacity, Dr. Schneier was responsible for strategic, organization-level capability assessment and development, performance metrics and business process design.
Prior to joining Biogen, Dr. Schneier was president of his own management consulting firm in Princeton, New Jersey, where he provided consulting services to more than 70 of the Fortune 100 companies, as well as several of the largest European and Asian firms. He also led consulting efforts at Organizational Dynamics in Boston, and was managing partner at Sibson & Company, a consulting firm in Princeton.
Dr. Schneier held a tenured professorship at the University of Maryland’s Smith School of Business and has held teaching positions at the business schools of the University of Michigan and Columbia University. He currently teaches at the Tuck School of Business, Dartmouth College. He received his B.A. and B.S. from Ohio State University and his Ph.D. and MBA from the University of Colorado.
Biogen is the world’s oldest independent biotechnology company and a leader in biologics research, development and manufacturing. A pioneer in leading edge research in immunology, neurobiology and oncology, Biogen brings novel therapies to improve patients’ lives around the world through its global marketing capabilities. For press releases and additional information about the company, please visit http://www.biogen.com.
Manager, Public Affairs
Tel: (617) 914-6524
Investment Community Contact:
Manager, Investor Relations
Tel: (617) 679-2812